Orogen Royalties Inc
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2020-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.organon.com
- Introduction
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 55
- Registration Number
- NCT00702585
Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)
Completed
- Conditions
- In Vitro Fertilization
- Interventions
- Biological: recFSH (follitropin alfa)Drug: gonadatropin releasing hormone (GnRH) antagonist ganirelixDrug: human chorion gonadatropin (hCG)Biological: progesteroneDrug: placebo-recFSH (follitropin alfa)Drug: placebo-corifollitropin alfaBiological: open-label recFSH
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 102
- Registration Number
- NCT00702546
Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)
Phase 2
Completed
- Conditions
- In Vitro FertilizationInfertility
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 99
- Registration Number
- NCT00702806
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)
Completed
- Conditions
- NeonatesPregnancy
- Interventions
- Drug: Corifollitropin alpha (MK-8962, Org 36286) 150 ugDrug: Corifollitropin alpha (MK-8962, Org 36286) 100 ugBiological: Recombinant follicle stimulating hormone (recFSH)Biological: Human chorionic gonadotprophin (hCG).
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 15
- Registration Number
- NCT00702520
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)
Completed
- Conditions
- NeonatesPregnancy
- Interventions
- Biological: recFSH (follitropin beta)Drug: gonadatropin releasing hormone (GnRH) antagonist ganirelixBiological: human chorion gonadotropin (hCG)Biological: progesteroneDrug: placebo-recFSH (follitropin beta)Drug: placebo-corifollitropin alfaBiological: open-label recFSH (follitropin beta)
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 113
- Registration Number
- NCT00702624
Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 44
- Registration Number
- NCT00702988
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 500
- Registration Number
- NCT00700661
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
Phase 3
Completed
- Conditions
- In Vitro Fertilization
- Interventions
- Biological: RecFSH / Follitropin beta (Days 1 to 7)Drug: Placebo RecFSH / follitropin betaDrug: Placebo Corifollitropin alfaBiological: RecFSH / Follitropin beta (Days 8 to hCG)Biological: hCGBiological: Progesterone
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 1509
- Registration Number
- NCT00696800
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
Phase 3
Completed
- Conditions
- In Vitro Fertilization
- Interventions
- Biological: FSHBiological: GnRH antagonistBiological: (rec)hCG
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 682
- Registration Number
- NCT00696878
A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)
Phase 2
Terminated
- Conditions
- Ovulation Induction
- Interventions
- Biological: human Chorion Gonadotropin (hCG)Biological: recombinant Follicle Stimulating Hormone (recFSH)Biological: hCG Bolus injection
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 8
- Registration Number
- NCT00697255